A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
about
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisPractical Application of Columbia Classification for Focal Segmental GlomerulosclerosisPodocytesAtypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literatureGlomerular diseases: FSGS.The effects of environmental chemicals on renal functionClinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeMYO1E mutations and childhood familial focal segmental glomerulosclerosis.Podocyte dysfunction in atypical haemolytic uraemic syndrome.Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.Potential urine proteomics biomarkers for primary nephrotic syndrome.Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literatureA best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital imagesCD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significanceCollapsing focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus.A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathyThe population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE)Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stressGlucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapyTwisted gastrulation, a BMP antagonist, exacerbates podocyte injuryPodocyte injury damages other podocytes.Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.Nephrin - a biomarker of early glomerular injury.Characterization and culture of fetal rhesus monkey renal cortical cells.Correlation of proteinuria with podocyte foot process effacement in IgA nephropathy: an ultrastructural study.Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathyFocal segmental glomerulosclerosis: molecular genetics and targeted therapiesProrenin receptor is essential for normal podocyte structure and functionMatrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cellsAssociation of histologic variants in FSGS clinical trial with presenting features and outcomesDesign of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.Notch Signaling Molecules Activate TGF- β in Rat Mesangial Cells under High Glucose Conditions.Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.Collapsing Glomerulopathy: A Single Centre Clinicopathologic Study of Seven Years.
P2860
Q24643421-73945D28-280A-404C-A92A-5FE845041C98Q26744237-36B6B53C-387A-4121-8418-50A5865D05A0Q26766118-79654891-D789-4636-A834-93303A272819Q26864297-70DA4073-4914-45F2-B3EF-AA23C1307BF0Q27687257-5A98A6F8-DAF5-4165-9C5A-1D054029A4BDQ28397401-D19282DF-9EC0-435B-8B14-0FE78B92EEE7Q30427819-08206317-BB63-4892-98DF-F063432B5FFFQ30541167-BFCD3475-093E-4E88-8C45-10A91AA28248Q33419853-C5A16CA5-EA5B-4AE4-B548-549969AED826Q33513803-9EBD4B5F-6003-4952-B1C8-202776F99C82Q33697151-39D8EA84-89EC-4619-9C98-93EC3155E2AFQ33735329-80013E75-0568-4EAD-B63A-3194CFD1A8B6Q33844319-5A8E6506-DBE5-45DE-A729-E6587A6C6C61Q33915270-2BD2C25D-7C68-4AF0-B68D-BDE386F878C1Q34060349-ADBDF163-CC29-46BC-926B-B3C9DA0D1799Q34087122-1B0513BD-8660-4B72-8636-28CE2AB8C92FQ34154720-69618408-0E41-413B-A16F-73394229E1A4Q34182007-AA56FBDB-3245-45EF-A9DA-44F3D1E67174Q34211618-D7ADCF1A-D107-459F-9BDD-6F1D99288584Q34421846-B088C880-8AFF-4F1D-A85B-8D959B7C8477Q34503209-9C7D05B0-85F2-4997-9508-C2EBDE9FB6F8Q34580772-4D99B0CB-4AF6-47A4-8F1D-B251EF6687EDQ34687329-112E43DB-511C-4D3A-8664-CF137453FDA4Q34773888-35160887-32FE-4064-BD4E-5DFBB054E239Q35056271-9281BE84-7DF4-41C5-A5AD-D4E5AB574A69Q35106728-F96FA63B-68BB-4482-BADB-724B8043A1ECQ35108875-99B490CF-D182-4417-A6D7-15FDEFE20EA9Q35121215-4F06C495-9E0D-4181-B3CC-AD1B89E8A258Q35186744-25D0BC8A-B967-464E-883B-0DC642FC08F2Q35219396-22403D9B-B64C-4414-A293-5CE50BAADEA5Q35287169-9197DAA3-C64F-41B3-A642-AC5FD03EC777Q35433416-9441610C-B0C6-40B9-BE01-0C391657FAB6Q35686453-CDFEEB93-405B-4257-ABC1-885CFE7F34CAQ35758252-7BBF0039-AC93-44D0-9833-860C5A1E000AQ36004045-9A68B268-D1AF-45CC-8351-6E6A5045627DQ36652814-212DE408-6306-47AE-B299-3BB5299FFC5DQ36728772-CE4A5E74-2232-40CE-BB65-1FE548FC5093Q36838149-B7A7EE8F-25F2-4DFC-AFF7-E1AFD44E1118Q36855889-BC304438-F7DC-4183-A0B5-2EF465065082Q36898777-E9040C31-1025-476B-AA61-35CD2997D138
P2860
A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A proposed taxonomy for the po ...... he primary nephrotic diseases.
@en
type
label
A proposed taxonomy for the po ...... he primary nephrotic diseases.
@en
prefLabel
A proposed taxonomy for the po ...... he primary nephrotic diseases.
@en
P356
P1476
A proposed taxonomy for the po ...... he primary nephrotic diseases.
@en
P2093
H William Schnaper
Laura Barisoni
P304
P356
10.2215/CJN.04121206
P577
2007-04-11T00:00:00Z